This site is intended for healthcare professionals
News

ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women.

Read time: 2 mins
Last updated:10th Nov 2020
Published:10th Nov 2020
Condition: HIV Prevention
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest